Hims & Hers Health Targets $6.5 Billion 2030 Revenue, Announces $250 Million Buyback
Hims & Hers Health aims for $6.5 billion in 2030 revenue and 10 million subscribers through international expansion and a $250 million share buyback. Growth exceeds 50% in weight-loss, diagnostics and international segments, with positive free cash flow and liquidity above $1.1 billion.
1. Expansion Through New Products and Acquisitions
Hims & Hers Health has launched four new direct-to-consumer wellness products in the past six months, including a personalized hormone therapy kit and an at-home sleep diagnostics device. The company completed two strategic acquisitions in Europe and Latin America, adding over 150,000 subscribers and extending its telehealth platform into three additional countries. Management expects these moves to boost quarterly active users by 25% year-over-year and establish a broader international presence by early 2027.
2. Ambitious 2030 Revenue and Subscriber Goals
The company is targeting $6.5 billion in annual revenue by 2030, up from approximately $500 million in the latest fiscal year. This plan relies on growing its subscriber base from 1.8 million to 10 million over the next seven years, representing a compounded annual growth rate of roughly 30%. Executives highlight a current runway of cross-sell opportunities—less than 20% of subscribers have tried the full suite of services—as a key driver to accelerate adoption and lift average revenue per user (ARPU) from $250 to over $400.
3. Share Buyback Signals Management Confidence
The board approved a $250 million share repurchase program in the most recent quarter, equal to nearly 10% of the company’s outstanding float. Management cited an undervalued share price relative to long-term earnings potential and signaled willingness to increase the program if buybacks prove accretive. Analysts estimate the repurchase will reduce share count by roughly 5% by year-end, enhancing per-share metrics and supporting return on equity in an environment where traditional marketing channels face rising costs.
4. Improving Unit Economics and Cash Flow Generation
Despite rapid expansion, Hims & Hers has maintained a structurally low customer acquisition cost—near $50 per subscriber compared to over $100 at peer telehealth firms—thanks to referral programs and platform personalization. EBITDA margins have held steady around 15%, with free cash flow turning positive in the last two quarters. The balance sheet carries over $1.1 billion in liquidity, providing ample capital for further market rollouts and product development without the need for equity raises.